72,500
Participants
Start Date
May 1, 2023
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
Typhoid conjugate Vaccine
TyphiBEV is a clear colourless monovalent vaccine containing 25 µg of Typhoid Vi polysaccharide manufactured using the Citrobacter freundii sensu lato3056 (Vi) and is conjugated to CRM 197 as a carrier protein. Sodium chloride and Phosphate buffer are used as a buffering agent in the vaccine formulation with 2-Phenoxyethanol as a preservative.
RECRUITING
Christian Medical College Vellore, Vellore
Bill and Melinda Gates Foundation
OTHER
University College, London
OTHER
Imperial College London
OTHER
Christian Medical College, Vellore, India
OTHER